Baker Avenue Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.65M Buy
51,784
+34,135
+193% +$4M 0.13% 130
2026
Q1
$2.12M Buy
17,649
+3,769
+27% +$435K 0.05% 208
2025
Q4
$1.46M Sell
13,880
-269
-2% -$25.3K 0.03% 232
2025
Q3
$1.19M Buy
14,149
+2,359
+20% +$194K 0.03% 242
2025
Q2
$933K Sell
11,790
-2,071
-15% -$165K 0.03% 245
2025
Q1
$1.24M Buy
13,861
+1,490
+12% +$139K 0.04% 228
2024
Q4
$1.23M Buy
12,371
+91
+0.7% +$9.38K 0.04% 222
2024
Q3
$1.39M Buy
12,280
+2,380
+24% +$283K 0.04% 214
2024
Q2
$1.23M Buy
9,900
+798
+9% +$103K 0.04% 207
2024
Q1
$1.2M Sell
9,102
-240
-3% -$29.6K 0.05% 201
2023
Q4
$1.02M Buy
9,342
+112
+1% +$11.6K 0.04% 202
2023
Q3
$950K Sell
9,230
-256
-3% -$27.6K 0.05% 206
2023
Q2
$1.09M Buy
9,486
+6,181
+187% +$702K 0.06% 180
2023
Q1
$352K Buy
3,305
+390
+13% +$42.1K 0.02% 289
2022
Q4
$323K Sell
2,915
-595
-17% -$60.8K 0.02% 292
2022
Q3
$302K Sell
3,510
-5,962
-63% -$532K 0.02% 285
2022
Q2
$864K Buy
9,472
+3,258
+52% +$289K 0.06% 165
2022
Q1
$510K Buy
6,214
+1,563
+34% +$123K 0.03% 218
2021
Q4
$356K Sell
4,651
-572
-11% -$45.6K 0.02% 250
2021
Q3
$392K Buy
+5,223
New +$397K 0.02% 201
2021
Q2
Sell
-3,182
Closed -$234K 250
2021
Q1
$234K Buy
3,182
+23
+0.7% +$1.7K 0.01% 220
2020
Q4
$246K Buy
3,159
+59
+2% +$4.51K 0.02% 214
2020
Q3
$245K Sell
3,100
-266
-8% -$20.8K 0.02% 199
2020
Q2
$248K Buy
+3,366
New +$253K 0.02% 208
2020
Q1
Sell
-21,466
Closed -$1.86M 239
2019
Q4
$1.86M Sell
21,466
-7,906
-27% -$649K 0.13% 115
2019
Q3
$2.36M Buy
29,372
+691
+2% +$55.4K 0.19% 86
2019
Q2
$2.29M Buy
28,681
+502
+2% +$38.4K 0.19% 87
2019
Q1
$2.24M Sell
28,179
-4,329
-13% -$324K 0.18% 89
2018
Q4
$2.37M Sell
32,508
-1,961
-6% -$138K 0.23% 84
2018
Q3
$2.33M Buy
34,469
+830
+2% +$52.9K 0.19% 92
2018
Q2
$1.95M Buy
33,639
+6,963
+26% +$393K 0.17% 98
2018
Q1
$1.39M Buy
26,676
+474
+2% +$25.6K 0.13% 117
2017
Q4
$1.41M Buy
26,202
+3,053
+13% +$169K 0.14% 113
2017
Q3
$1.41M Buy
23,149
+2,300
+11% +$139K 0.16% 96
2017
Q2
$1.27M Buy
20,849
+2,582
+14% +$157K 0.17% 85
2017
Q1
$1.11M Buy
18,267
+2,425
+15% +$147K 0.15% 94
2016
Q4
$890K Buy
15,842
+506
+3% +$29.6K 0.12% 98
2016
Q3
$913K Sell
15,336
-296
-2% -$17.3K 0.13% 99
2016
Q2
$859K Buy
15,632
+743
+5% +$39.5K 0.13% 101
2016
Q1
$752K Buy
14,889
+2,587
+21% +$127K 0.11% 99
2015
Q4
$620K Sell
12,302
-2,237
-15% -$113K 0.09% 110
2015
Q3
$685K Buy
14,539
+3,212
+28% +$171K 0.12% 94
2015
Q2
$615K Buy
11,327
+639
+6% +$35.8K 0.08% 144
2015
Q1
$586K Sell
10,688
-66,322
-86% -$3.76M 0.08% 140
2014
Q4
$4.17M Sell
77,010
-2,241
-3% -$125K 0.58% 43
2014
Q3
$4.48M Buy
79,251
+1,907
+2% +$107K 0.63% 32
2014
Q2
$4.27M Buy
77,344
+1,116
+1% +$60.9K 0.62% 38
2014
Q1
$4.13M Buy
+76,228
New +$3.95M 0.69% 30
2013
Q4
Sell
-21,274
Closed -$966K 273
2013
Q3
$966K Sell
21,274
-54,416
-72% -$2.48M 0.2% 100
2013
Q2
$3.38M Buy
+75,690
New +$3.38M 0.83% 28

Other funds holding MRK

Baker Avenue Asset Management's MRK Position: Q2 2026 in Review

Baker Avenue Asset Management increased its Merck (MRK) stake by 193% in Q2 2026, buying an estimated $4M and bringing the position to 51,784 shares worth $6.65M. The position accounts for 0.13% of the portfolio, ranked #130.

Baker Avenue Asset Management first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Baker Avenue Asset Management held 51,784 shares of Merck worth $6.65M as of Q2 2026.
  • Baker Avenue Asset Management bought 34,135 Merck shares in Q2 2026, an estimated $4M.
  • Merck made up 0.13% of Baker Avenue Asset Management's portfolio in Q2 2026, its #130 holding.
  • Baker Avenue Asset Management first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.